CryoLife, Inc. (CRY) Reports In-Line Q3 EPS, Offers Insight on FY11 Outlook
Get Alerts CRY Hot Sheet
Price: $15.61 +0.06%
Financial Fact:
General, administrative, and marketing: 20.59M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
General, administrative, and marketing: 20.59M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
CryoLife, Inc. (NYSE: CRY) reported Q3 adjusted EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $30.64 million.
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share